Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial
暂无分享,去创建一个
H. Scheepers | T. Hasaart | J. Duvekot | K. Boer | F. Vandenbussche | K. Bloemenkamp | H. Bruinse | M. Wouters | J. Erwich | J. Santema | B. Mol | A. Lim | P. Hummel | C. M. van Oirschot | W. Schöls | J. Offermans
[1] Bethany J Figg,et al. National Institute of Child Health and Human Development , 2013 .
[2] S. Gates,et al. How should randomised trials including multiple pregnancies be analysed? , 2004, BJOG : an international journal of obstetrics and gynaecology.
[3] R. P. Heine,et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. , 2003, The New England journal of medicine.
[4] A. A. Bamigboye,et al. Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes. , 2003, The Cochrane database of systematic reviews.
[5] M. Zugaib,et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. , 2003, American journal of obstetrics and gynecology.
[6] J. Kleijnen,et al. Accuracy of cervical transvaginal sonography in predicting preterm birth: a systematic review. , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[7] D. Wing,et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial , 2001, JAMA.
[8] G. Thurnau,et al. The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1998, American journal of obstetrics and gynecology.
[9] Chin-peng Lee,et al. The Preterm Prediction Study: Recurrence risk of spontaneous preterm birth , 1998 .
[10] R. Gray,et al. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation. , 1992, Contraception.
[11] M. Keirse. Progestogen administration in pregnancy may prevent preterm delivery , 1990, British journal of obstetrics and gynaecology.
[12] S. Harlap,et al. Aggression, physical activity levels and sex role identity in teenagers exposed in utero to MPA. , 1989, Contraception.
[13] J. Yovich,et al. Medroxyprogesterone Acetate Therapy in Early Pregnancy Has No Apparent Fetal Effects , 1989, Teratology.
[14] Manuel Calderón Sánchez,et al. Long-term effects of MPA on human progeny: intellectual development. , 1988, Contraception.
[15] Z. Katz,et al. Teratogenicity of Progestogens Given During the First Trimester of Pregnancy , 1985, Obstetrics and gynecology.
[16] W. O'Fallon,et al. Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974. , 1985, Fertility and sterility.
[17] Pre-publication history , 2001 .